Toshiba mid-tier CT gets FDA nod

Article

Toshiba America Medical Systemsreceived Food and Drug Administration clearance this month forXvision, its mid-tier helical CT scanner. Toshiba, of Tustin,CA, has been revamping its helical CT line since rolling out thepremium Xpress/SX scanner last year

Toshiba America Medical Systemsreceived Food and Drug Administration clearance this month forXvision, its mid-tier helical CT scanner. Toshiba, of Tustin,CA, has been revamping its helical CT line since rolling out thepremium Xpress/SX scanner last year (SCAN 11/17/93 and 4/20/94).

Xvision is about half the size and nearly a third lighter thanstandard helical scanners and uses the same console as Xpressand the nonhelical Xpeed scanner. Xvision's gantry has been redesigned,however.

Toshiba hopes that Xvision will find expanded applicationsfor CT technology, such as the use of volumetric CT imaging inthe operating room to guide surgery.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.